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Background: To describe the clinicopathological characteristics of a series of head and neck rhabdomyosarcoma 
(RMS) and to review the literature.
Material and Methods: Cases diagnosed as RMS affecting the head and neck region were retrospectively retrieved 
from the files of two Brazilian institutions from January 2006 to January 2017. Data on clinical features (sex, age 
and affected site), microscopic subtype, immunohistochemical results, treatment employed and follow-up status 
were obtained from the patient’s medical charts.
Results: During the period considered, 10 cases of RMS were identified. Females predominated (4M:6F), the mean 
age at diagnosis was 16.5 years-old and the orbit was the most affected site (4 cases). Microscopically, most cases 
were classified as embryonal RMS (6 cases) and the Desmin/Myogenin/Myo-D1 immunohistochemical positivity 
was useful to confirm the diagnosis. Chemotherapy and radiotherapy were applied to 9 and 8 patients respectively, 
whereas 2 patients were treated by surgery. Recurrences occurred in 3 patients and distant metastasis in 2 cases. 
Nine patients were alive in their last follow-up, 3 of them with disease, whereas 1 patient died due to the disease.
Conclusions: Head and neck RMS is an aggressive malignant neoplasm which demands especial concern to 
achieve early diagnosis and successful treatment. 
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Introduction
Rhabdomyosarcoma (RMS) is classified by the World 
Health Organization as a skeletal muscle tumor arising 
from undifferentiated skeletal tissue (1,2), predomi-
nantly affecting the head and neck region, with approxi-
mately 40% of the cases involving this area (3-5). RMS 
is the most common soft tissue sarcoma in children, ac-
counting for 4.5% of all pediatric malignant neoplasms 
and approximately 50% of the solid malignancies diag-
nosed in patients under 10 years old (6). On the other 
hand, adult RMS is more commonly observed in the 
extremities, rarely affecting the head and neck (7).
RMS are highly sensitive to chemotherapy and radio-
therapy, as a consequence, over the last 30 years pe-
diatric patients had a significant improvement in their 
prognosis, with the 5-year survival rates achieving 80% 
to 85% in some series (4,8,9). Nevertheless, the outcome 
for adults is not as satisfactory as for the pediatric pa-
tients and both children and adults are currently treated 
by aggressive surgical resections followed by chemo-
therapy and radiotherapy (10).
In this study we aim to describe the clinicopathological 
characteristics of a series of head and neck RMS.   
Material and Methods
All cases diagnosed as RMS affecting the head and 
neck region were retrospectively retrieved from the 
files of the Oral Pathology Service of the João de Barros 
Barreto University Hospital (Belém/Brazil) and from 
the Pathology Department of the Sírio-Libanês Hospital 
(São Paulo/Brazil) from January 2006 to January 2017. 
Data on clinical features (sex, age and affected site), 
microscopic subtype, immunohistochemical results, 
treatment employed and follow-up status were obtained 
from the patient’s medical charts and descriptively pre-
sented. This study was approved by the local Ethical 
Committee.
Results
During the 11-year period investigated, 10 cases di-
agnosed as RMS were identified. The clinical and 
pathological data of these patients are summarized in 
Table 1. Briefly, there was a slight female predominance 
(4M:6F;) with a mean age at diagnosis of 16.5 years-old 
(range 6 to 38 years). The orbit was the most affected 
site (4 cases), followed by the oral cavity (3 cases) (Fig. 
1). Microscopically, most of the cases presented as em-
bryonal RMS (6 cases) characterized by small, round, 
hypercromatic neoplastic cells with the so-called rhab-
doid cells showing large eosinophilic cytoplasm and 
displaced nuclei. Two cases presented as undifferenti-
ated high-grade sarcomas with severe cellular pleo-
morphism, frequent atypical mitoses and variable areas 
of necrosis. One case was classified as the spindle cell 
variant characterized by elongated neoplastic cells with 
Table 1. Clinicopathological and follow-up data of 10 cases of head 
and neck rhabdomyosarcoma.
* Time of follow-up comprises the time difference between the diag-
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scarce eosinophilic cytoplasm and the presence of “her-
ringbone” growth pattern in some areas, and one case 
of  the alveolar variant with neoplastic nests present-
ing loosely arranged central cells and peripheral ones 
tightly attached to the surrounding connective tissue 
(Fig. 2).
All cases were positive for desmin, myogenin and 
MyoD1 antigens. Pan-cytokeratin (AE1/AE3) was ex-
pressed in two cases and Ki67 proliferative index was 
high in all tumors ranging from approximately 70 to 
over 90% (Fig. 3). Nine patients received chemotherapy, 
and radiotherapy was applied to 8 individuals. Only 2 
patients were submitted to surgery. Nine patients were 
alive after a follow-up period that ranged from 1 to 72 
months. However, recurrences were seen in 3 cases and 
distant metastases in 2 cases. Three patients remained 
alive with disease, and 1 patient died of disease. Fig. 3. Immunohistochemical features of RMS. A) Vimentin (DAB; 200X), B) Cytokeratin (DAB; 100X), C) Desmin (DAB; 200X), D) 
MyoD1 (DAB; 100X) and E) Myogenin (DAB; 100X). F) Ki67 proli-
ferative index achieved 90% in some cases (DAB; 100X).
Fig. 1. Clinical presentation of the three cases of RMS affecting the 
oral cavity. A) Case 1. Embryonal RMS causing a significant facial 
asymmetry. B) Intra-oral exam revealed a diffuse ill-defined soft-
tissue neoplasm with irregular surface and areas of necrosis. C) Case 
2. Embryonal RMS affecting the maxillary mucosa of a 23 year-old 
female patient causing a painful swelling with ulcerative regions. D) 
Case 3. Embryonal RHS affecting the cheek mucosa of a 10-year old 
female patient. Areas of necrosis are easily seen. E) Clinical pre-
sentation of one case of RMS affecting the orbit and the maxillary 
sinus of a 38-year-old male patient. F) Computed tomography dem-
onstrated that left maxillary sinus was completely obliterated by the 
neoplasm.  
Fig. 2. Microscopic findings of RMS. A and B) Case 1 diagnosed as 
embryonal RMS consisting of undifferentiated neoplastic cells, with 
atypical mitosis and extensive areas of necrosis (H&E; 100X and 
200X, respectively). C and D) Case 2 diagnosed as embryonal RMS 
with poorly differentiated small round cells, and scattered rhabdo-
myoblasts (H&E; 100X and 200X, respectively). E and F) Case 3 
classified as spindle cell RMS predominantly composed of elongated 
malignant cells (H&E; 100X and 200X, respectively).  
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Discussion
RMS is a mesenchymal malignant neoplasm with skele-
tal muscle differentiation that represents the most com-
mon soft tissue sarcoma in the pediatric population. 
Approximately 40% of the cases develop in the head 
and neck region and the appropriate treatment demands 
a multi-modality approach (5,6,11-13). In this study we 
described a series of 10 cases of head and neck RMS 
and reviewed all published clinical series dealing with 
RMS of the head and neck with at least 3 cases reported 
to better understand the clinicopathological features of 
this aggressive malignancy (Table 2,2 continue, 2 con-
tinue-1, 2 continue-2, 2 continue-3.).
In contrast to our series where females predominated, 
in the literature RMS presents a slight male predilec-
tion, with a male:female ratio of 1.5:1 (5,6,11,12,14). 
Clinical signs and symptoms mainly depend on the af-
fected site and may vary considerably. Some cases are 
asymptomatic, although a painful swelling is the most 
common clinical manifestation in the head and neck re-
gion, usually causing facial asymmetries(15-19). Other 
complains may also be observed, including proptosis, 
nasal stuffiness and nasal discharge(15,19-24). In ad-
dition, as observed in one case of our series where an 
infectious lesion was initially clinically considered, 
misdiagnosis may also occur, potentially leading to an 
incorrect therapeutic approach and significant delay to 
achieve the correct diagnosis (20,25).
Microscopically, RMS can be classified into different 
histologic subtypes, and as shown in our study, the most 
common is the embryonal subtype (EMB), accounting 
for 60% of all cases, characterized by undifferenti-
ated, small, round and hypercromatic cells with vari-
able number of strap or tadpole-shaped, eosinophilic 
rhabdomyoblasts (11,20). Alveolar subtype (ALV) rep-
resents approximately 30% of the cases, and it is char-
acterized by small round rhabdomyoblasts arranged 
in nests separated by connective tissue trabeculae and 
focal areas of alveolar architecture with hypercromat-
ic nuclei and eosinophilic cytoplasm (11,15,16). ALV 
RMS is more common in older patients than EMB, 
ranging between 10 and 25 years-old with no gender 
predilection and usually with a more unfavorable prog-
nosis (8,11,16,26). Moreover, approximately 75% of 
ALV carry a chromosomal translocation that results 
in the fusion of two transcript factor-encoding genes, 
the PAX3 gene (or less commonly PAX7 gene) and the 
FOXO1 gene, resulting in the expression of the chimeric 
PAX3/7-FOXO1 protein (7). 
Other less common variants include the pleomorphic 
RMS that only rarely occurs in the pediatric group and 
comprises about 5% of all cases diagnosed (11,17); the 
spindle cell subtype that has previously been consid-
ered a variant of the EMB, but it is now recognized as a 
separate subtype (1); and the botryoid variant that rep-
resents an EMB subtype with a grapelike macroscopic 
and histologic appearance caused by sub-epithelial tu-
mor aggregates (21). More recently, a sclerosing RMS 
was also recognized (27). In our series, two cases were 
diagnosed as pleomorphic RMS, one case showed fea-
tures consistent with the spindle cell variant and one 
was classified as ALV. Immunohistochemistry is very 
important to confirm the diagnosis, especially in un-
differentiated cases, and to exclude other neoplasms 
with cells demonstrating rhabdomyoblast-like features. 
Positivity to desmin, myogenin and MyoD1, as demon-
strated in this study, is the main profile currently used.
Significant improvements were achieved in the treat-
ment of RMS over the last decades and multimodality 
treatment has been established as the recommended 
therapy for these patients with a combination of che-
motherapy, radiation, and surgery. In cases where ana-
tomical location allows total tumor resection, surgery is 
indicated followed by radiotherapy and chemotherapy. 
Where free surgical margins are not possible to be ob-
tained, chemotherapy and radiotherapy is applied(6,18). 
In our series, most cases were treated by chemotherapy 
combined with radiotherapy, whereas only two patients 
were submitted to surgical resection of their tumors; 
this finding is explained by the advanced tumor stages 
observed, some of them very close to vital structures, 
which impaired an adequate removal.
The most common cause of death is tumor progression 
and involvement of adjacent structures (8,10,12,19). 
Regarding distant metastases, the most commonly in-
volved site is the lung (5,7,28,29), but other locations 
can also be affected (28). In our sample, three patients 
presented local recurrences, and two distant metastases.
Primary location of the disease may significantly influ-
ence the patients’ outcome, since parameningeal areas, 
paranasal sinus, nasal cavity, mastoid area and infra-
temporal fossa tends to present a poorer prognosis than 
non-parameningeal cases, which may be consequence 
of the impossibility to achieve total resection of the 
neoplasms and due to their proximity to intracranial 
area (7,10). The size of the tumor in the moment of the 
diagnosis may also represent an important factor, with 
lesions greater than 5cm presenting a worse prognosis; 
similarly, adult patients are also considered to carry 
lower survival rates than infants (6,10). 
In conclusion, RMS is an aggressive malignant soft 
tissue neoplasm that usually affects the head and neck 
region, including the oral cavity. Recent improvements 
in the therapeutic approaches significantly increased 
survival rates, but an early diagnosis is mandatory to 
achieve the appropriate management of these patients.
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